Design Therapeutics (NASDAQ:DSGN) Stock Rating Upgraded by Wells Fargo & Company
Design Therapeutics (NASDAQ:DSGN – Get Free Report) was upgraded by Wells Fargo & Company to a “strong-buy” rating in a report issued on Friday, Zacks reports. Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Design Therapeutics in a report on Friday, July 17th. Two analysts have rated the stock with a Strong […]
3 Oct 06:01 · The Cerbat Gem